Physician profile
Tiffany Johnson
NPI 1740899459
$918.16
in general payments reported to CMS, 2019-2025
13 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.10 · 2022: $260 · 2023: $154 · 2024: $230 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $334.38 | 2023-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Boston Scientific Corporation | $150.00 | 2025 | Watchman Flx |
| Pfizer INC. | $98.72 | 2022 | |
| Myovant Sciences INC. | $92.05 | 2021-2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $53.14 | 2024 | |
| Abbvie INC. | $48.51 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.35 | 2023 | |
| Covis Pharma Gmbh | $23.60 | 2022 | |
| Teleflex LLC | $23.08 | 2022 | |
| Novo Nordisk INC | $19.88 | 2023 | Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $14.42 | 2022 | |
| Medtronic, INC. | $14.27 | 2022 | |
| Procept Biorobotics Corporation | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.